Name | Fazpilodemab |
---|
Description | Fazpilodemab (BFKB8488A) is a humanized, agonistic, bispecific antibody targeting fibroblast growth factor receptor 1c (FGFR1c) and Klothoβ. Fazpilodemab can be used for the research of type 2 diabetes mellitus (T2DM) or nonalcoholic fatty liver disease (NAFLD)[1]. |
---|---|
Related Catalog | |
Target |
FGFR1c Klothoβ |
References |
No Any Chemical & Physical Properties |